Company Profile

Accacia International LLC provides expertise and capabilities in the field of research, development and commercialization of rapid diagnostic bioassays and detection instruments for the clinical, veterinary, agricultural and bio-defense markets. The firm’s core competency is based on solid or liquid phase bimolecular detection utilizing reflectance, fluorescence intensity and fluorescence polarization technologies. The firms AccaciaGold technology is a point-of-care diagnostic platform designed to dia'gnose infectious disease like Tuberculosis, Dengue & West Nile Virus. The device uses an isothermal amplification based assay to detect nucleic acid signatures that are exclusively found in pathogens. The firm also has designed a portable battery powered instrument to house the assay to provide a complete platform. The potential for this device is huge for developed regions to limited resource areas. This device requires no specialized equipment and a minimum of technical training